AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
BUFEXAMAC
4 registrations across 3 African markets— 3 active
Markets with BUFEXAMAC
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| PARFENAC* | 🇿🇦South Africa | SOUTH AFRICAN CYANAMID (PTY) LTD | suspended | Apr 2022 |
| BUFAMAC crème dermique / 5 g | 🇸🇳Senegal | OPALIA | active | — |
| PARFEDERM crème dermique / 5% | 🇸🇳Senegal | PHARMAGREB | active | — |
| PARFENAC 5% CREME | 🇲🇦Morocco | — | active | — |
BUFEXAMAC in Africa — Regulatory Overview
BUFEXAMAC is registered across 3 African markets with 4 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Senegal, Morocco, South Africa. AfricaRegulatory refreshes this data daily from official government sources.
Of the 4 registrations, 3 (75%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.